{
    "bipacksedel": {},
    "produktresume": {},
    "fass_text": {},
    "bilder_och_delbarhet": {},
    "miljöinformation": {
        "env-effect": "Miljöinformationen för azelastin är framtagen av företaget Meda för Allergodil, Azeflu, Lastinaz, Xatalin Miljörisk: Användning av azelastin har bedömts medföra försumbar risk för miljöpåverkan. Nedbrytning: Azelastin är potentiellt persistent. Bioackumulering: Azelastin har låg potential att bioackumuleras. Läs mer Detaljerad miljöinformation Detailed background information Environmental Risk Classification Predicted Environmental Concentration (PEC) PEC is calculated according to the following formula: PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.5*10-6*A(100-R) PEC = 3.47 * 10-4 μg/L Where: A =2.31 kg (total amount API of azelastine hydrochloride in Sweden year 2020, data from IQVIA) (Ref. 1). R = removal rate = 0% (no data available) P = number of inhabitants in Sweden = 10*106 V (L/day) = volume of waste water per capita and day = 200 (ECHA default) (Ref.2 chapter R.2) D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (Ref.2 chapter R.2) Predicted No Effect Concentration (PNEC) Ecotoxicological studies Desmodesmus subspicatus (green algae) (OECD 201) (ref. 3) NOEC 72 hours (growth rate) = 0.37 mg/L NOEC 72 hours (AUC) = 0.37 mg/L NOEC 72 hours (yield) = 0.37 mg/L ErC50 72 hours = 4.9 mg/L EbC50 72 hours = 1.5 mg/L EyC50 72 hours = 1.2 mg/L Daphnia magna (crustacea) (ref. 4) NOEC 21 days (reproduction) = 0.29 mg/L (OECD 211) Danio rerio (zebra fish) (ref. 5) NOEC 30 days (mortality) = 0.11 mg/L (OECD 210) NOEC 30 days (hatching phase) = 0.11 mg/L (OECD 210) Respiration inhibition test in aerobic bacteria (OECD 209) (ref. 6) NOEC 3 hours = 10 mg/L EC50 3 hours = 53 mg/L For the calculation of PNEC, long-term NOEC for the most sensitive species is used. Fish obtained the lowest value of NOEC and is thus considered to be the most sensitive species. Long-term toxicity results for three species across three trophic levels (fish, crustacean and algae) justifies an assessment factor (AF) of 10 according to ECHA guideline (Ref.2 chapter R.10). PNEC is calculated as NOEC (fish)/10 (AF) PNEC = 11 μg/L Environmental risk classification (PEC/PNEC ratio) PEC/PNEC = 3.47 * 10-4 / 11 = 31.5 * 10-6 μg/L PEC/PNEC < 0.1 which justifies the phrase “Use of Azelastine has been considered to result in insignificant environmental risk”. Degradation Azelastine is not ready biodegradable, <60% biotic degradation in 28 days, no abiotic degradation observed during study period. (OECD 301B) (Ref. 7) Azelastine fails to meet the criteria for ready biodegradability and no abiotic degradation is observed. No data regarding inherent biodegradability or simulation studies are available. The substance is assigned the phrase ”Azelastine is potentially persistent”. Bioaccumulation Experimentally derived Log Kow values for Azelastine range from 1.00 to 3.85 depending on pH and initial concentration (shake flask method, FDA technical assistance handbook, section §3.02) (Ref. 8). Log Kow < 4 which justifies use of the phrase “Azelastine has low potential for bioaccumulation”. References: Data from IQVIA ”Consumption assessment in kg for input to environmental classification – updated 2021 (data 2020) ECHA, European Chemicals Agency. Guidance on information requirements and chemical safety assessment. Ver 2.1, 2011 Determination of 72h-EC50 of Azelastine hydrochloride in Desmodesmus subspicatus according to OECD 201 resp. EU C.3, Meda internal document 2011 Determination of the effects on reproduction of Daphnia magna after exposition to Azelastine hydrochloride according to OECD 211 resp. EU C.20, Meda internal document 2011 Determination of the toxicity in the early-life stage toxicity test of Azelastine hydrochloride against Danio rerio Hamilton-Buchanan following OECD Guideline 210, Meda internal document 2011 Determination of the inhibition of the respiration of activated sludge when exposed to Azelastine hydrochloride according to OECD 209 resp. EU C.11, Meda internal document 2011 Determination of the aerobe ready biodegradability of Azelastine hydrochloride in the CO2 evolution test following OECD 301B resp. EU C.4.C, Meda internal document 2011 Environmental risk assessment (Non-GMO) on Azelastine hydrochloride, Meda internal document 2011"
    },
    "skyddsinfo": {},
    "product_name": {
        "product_name": "Lastin®, Ögondroppar, lösning 0,5 mg/ml"
    }
}